These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

766 related articles for article (PubMed ID: 24931443)

  • 1. Dynamic analysis of oral Candida carriage, distribution, and antifungal susceptibility in HIV-infected patients during the first year of highly active antiretroviral therapy in Guangxi, China.
    Jiang L; Yong X; Li R; Peng Y; Liu W; Qin Q; Zhang L; Liu Z; Liang H; Tao R
    J Oral Pathol Med; 2014 Oct; 43(9):696-703. PubMed ID: 24931443
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oral Candida isolates among HIV-infected subjects in Nigeria.
    Nweze EI; Ogbonnaya UL
    J Microbiol Immunol Infect; 2011 Jun; 44(3):172-7. PubMed ID: 21524610
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oral Candida colonization and its relation with predisposing factors in HIV-infected children and their uninfected siblings in Brazil: the era of highly active antiretroviral therapy.
    Cerqueira DF; Portela MB; Pomarico L; de Araújo Soares RM; de Souza IP; Castro GF
    J Oral Pathol Med; 2010 Feb; 39(2):188-94. PubMed ID: 20040023
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Point prevalence, microbiology and antifungal susceptibility patterns of oral Candida isolates colonizing or infecting Mexican HIV/AIDS patients and healthy persons.
    Sánchez-Vargas LO; Ortiz-López NG; Villar M; Moragues MD; Aguirre JM; Cashat-Cruz M; Lopez-Ribot JL; Gaitán-Cepeda LA; Quindós G
    Rev Iberoam Micol; 2005 Jun; 22(2):83-92. PubMed ID: 16107165
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Asymptomatic oral yeast carriage and antifungal susceptibility profile of HIV-infected patients in Kunming, Yunnan Province of China.
    Li YY; Chen WY; Li X; Li HB; Li HQ; Wang L; He L; Yang XP; Wang XC; Huang YL; Yao YG
    BMC Infect Dis; 2013 Jan; 13():46. PubMed ID: 23356471
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Candida spp. in vitro susceptibility profile to four antifungal agents. Resistance surveillance study in Venezuelan strains.
    Panizo MM; Reviákina V; Dolande M; Selgrad S
    Med Mycol; 2009 Mar; 47(2):137-43. PubMed ID: 18651308
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antifungal effect of mouth rinses on oral Candida counts and salivary flow in treatment-naïve HIV-infected patients.
    Patel M; Shackleton JA; Coogan MM; Galpin J
    AIDS Patient Care STDS; 2008 Aug; 22(8):613-8. PubMed ID: 18627277
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Species distribution and antifungal susceptibility profile of oral candida isolates from HIV-infected patients in the antiretroviral therapy era.
    Costa CR; de Lemos JA; Passos XS; de Araújo CR; Cohen AJ; Souza LK; Silva Mdo R
    Mycopathologia; 2006 Jul; 162(1):45-50. PubMed ID: 16830191
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dynamics of T-cell subsets and their relationship with oral and systemic opportunistic infections in HIV/AIDS patients during the first year of HAART in Guangxi, China.
    Zhang L; Huang Y; Liu Z; Liu W; Qin Q; Tao R
    J Med Virol; 2015 Jul; 87(7):1158-67. PubMed ID: 25777553
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Iranian HIV/AIDS patients with oropharyngeal candidiasis: identification, prevalence and antifungal susceptibility of Candida species.
    Khedri S; Santos ALS; Roudbary M; Hadighi R; Falahati M; Farahyar S; Khoshmirsafa M; Kalantari S
    Lett Appl Microbiol; 2018 Oct; 67(4):392-399. PubMed ID: 30019443
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro susceptibility of oral Candida to seven antifungal agents.
    Kuriyama T; Williams DW; Bagg J; Coulter WA; Ready D; Lewis MA
    Oral Microbiol Immunol; 2005 Dec; 20(6):349-53. PubMed ID: 16238594
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cross-sectional study of the susceptibility of Candida isolates to antifungal drugs and in vitro-in vivo correlation in HIV-infected patients.
    Chavanet P; Lopez J; Grappin M; Bonnin A; Duong M; Waldner A; Buisson M; Camerlynck P; Portier H
    AIDS; 1994 Jul; 8(7):945-50. PubMed ID: 7946104
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oral Candida albicans isolates with reduced susceptibility to fluconazole in Swedish HIV-infected patients.
    Chryssanthou E; Torssander J; Petrini B
    Scand J Infect Dis; 1995; 27(4):391-5. PubMed ID: 8658076
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oral candidiasis of HIV-infected children undergoing sequential HIV therapies.
    Melo NR; Taguchi H; Culhari VP; Kamei K; Mikami Y; Smith SN; Vilela MS
    Med Mycol; 2009 Mar; 47(2):149-56. PubMed ID: 18651304
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Significance of isolation and drug susceptibility testing of non-Candida albicans species causing oropharyngeal candidiasis in HIV patients.
    Nadagir SD; Chunchanur SK; Halesh LH; Yasmeen K; Chandrasekhar MR; Patil BS
    Southeast Asian J Trop Med Public Health; 2008 May; 39(3):492-5. PubMed ID: 18564689
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Salivary lactoferrin in HIV-infected children: correlation with Candida albicans carriage, oral manifestations, HIV infection and its antifungal activity.
    Alves TP; Simões AC; Soares RM; Moreno DS; Portela MB; Castro GF
    Arch Oral Biol; 2014 Aug; 59(8):775-82. PubMed ID: 24837476
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multiple oral Candida infections in patients with Sjogren's syndrome -- prevalence and clinical and drug susceptibility profiles.
    Yan Z; Young AL; Hua H; Xu Y
    J Rheumatol; 2011 Nov; 38(11):2428-31. PubMed ID: 21844143
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oral Candida colonization in HIV-infected patients in Londrina-PR, Brazil: antifungal susceptibility and virulence factors.
    Paula SB; Morey AT; Santos JP; Santos PM; Gameiro DG; Kerbauy G; Sena EM; Ueda LT; Carneiro M; Pinge-Filho P; Yamauchi LM; Yamada-Ogatta SF
    J Infect Dev Ctries; 2015 Dec; 9(12):1350-9. PubMed ID: 26719941
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The evolution of Candida species and fluconazole susceptibility among oral and vaginal isolates recovered from human immunodeficiency virus (HIV)-seropositive and at-risk HIV-seronegative women.
    Sobel JD; Ohmit SE; Schuman P; Klein RS; Mayer K; Duerr A; Vazquez JA; Rampalo A;
    J Infect Dis; 2001 Jan; 183(2):286-93. PubMed ID: 11204125
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The prevalence, risk factors and antifungal sensitivity pattern of oral candidiasis in HIV/AIDS patients in Kumba District Hospital, South West Region, Cameroon.
    Ambe NF; Longdoh NA; Tebid P; Bobga TP; Nkfusai CN; Ngwa SB; Nsai FS; Cumber SN
    Pan Afr Med J; 2020; 36():23. PubMed ID: 32774600
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 39.